Ex Parte Wong et al - Page 4



                Appeal No. 2004-0450                                                                             Page 4                   
                Application No. 09/785,936                                                                                                

                        Claims 79 through 94, 97 through 111, 113 through 118, and 120 through 129                                        
                stand rejected under 35 U.S.C. § 102 as anticipated by or, in the alternative, under 35                                   
                U.S.C. § 103 as unpatentable over the ‘343 patent.  This reference discloses a method                                     
                for producing a phytate-free or low phytate soy protein isolate and concentrate using                                     
                one or more phytate-degrading enzymes.  The ‘343 patent discloses phytate-degrading                                       
                enzymes which include phytases and acid phosphatases.  “Particularly preferred for the                                    
                purposes of the present invention are the Finase enzymes” (‘343 patent, page 6, line                                      
                26).  It is undisputed on this record that Finase is a commercially available enzyme                                      
                preparation containing both phytase and acid phosphatase.1                                                                
                        The examiner’s main argument is that, although the prior art does not explicitly                                  
                disclose the degradation of RNA, a person having ordinary skill in the art, armed with                                    
                the disclosure of the ‘343 patent and carrying out its method using the preferred                                         
                enzyme, Finase, would inevitably and necessarily degrade RNA present in the soy                                           
                protein.2                                                                                                                 


                        According to applicants, claim 79 is not anticipated by the cited prior art because:                              
                        [T]he ‘343 patent does not disclose 1) the degradation of ribonucleic                                             
                        acids; 2) where the ribonucleic acid degradation is effected with an acid                                         


                        1   “A combination of phytase and a pH 2.5 optimum acid phosphatase form A. niger has been                        
                used by Alko, Ltd. as an animal feed supplement in their phytic acid degradative product Finas [sic] F and                
                Finase S.”  U.S. Patent No. 6,190,897 issued February 20, 2001, to Kretz, column 2, lines 18 through 22                   
                (copy enclosed with this opinion).                                                                                        
                        2   See the Final Rejection (Paper No. 9, page 3), “the degradation of RNA is inherent to the                     
                enzyme digestion of the vegetable protein as disclosed by the cited reference;” and see the Examiner’s                    
                Answer (Paper No. 15, page 5), “RNAs are inherently degraded by the acid phosphatase present in the                       
                Finase enzyme of the cited disclosure.”                                                                                   





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007